Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Understanding the benefits and challenges of first-line cyclin-dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women.

Azim HA, Dawood S, El-Saghir N, Kassem L, Azim HA Jr.

Breast J. 2019 Nov 10. doi: 10.1111/tbj.13637. [Epub ahead of print]

PMID:
31709685
2.

Personalized Medicine, Genomic Profiling and Germline Mutations: Toward More Precise Decisions.

Awada A, El Saghir NS.

J Oncol Pract. 2019 Sep;15(9):e755-e757. doi: 10.1200/JOP.19.00500. No abstract available.

PMID:
31509719
3.

BRCA mutations in a cohort of Iraqi patients presenting to a tertiary referral center.

Farra C, Dagher C, Hamadeh L, El Saghir N, Mukherji D.

BMC Med Genet. 2019 Sep 5;20(1):154. doi: 10.1186/s12881-019-0885-9.

4.

Could no-fault compensation for medical errors improve care and reduce costs?

Howard A, McWilliams T, Hannant G, Saghir N, Giannoudis P, Scott J.

Br J Hosp Med (Lond). 2019 Jul 2;80(7):387-390. doi: 10.12968/hmed.2019.80.7.387.

5.

Female oncologists in the Middle East and North Africa: progress towards gender equality.

Salem R, Haibe Y, Dagher C, Salem C, Shamseddine A, Bitar N, Makdessi J, Khatib S, Boussen H, Benna F, Al Sukhun S, El Saghir N, Temraz S, Mukherji D.

ESMO Open. 2019 Jun 14;4(3):e000487. doi: 10.1136/esmoopen-2019-000487. eCollection 2019.

6.

Formula companies' responsibility for burns awareness.

Saghir N, Stallard J, Saghir R, Anwar U.

BMJ. 2019 Jan 29;364:l393. doi: 10.1136/bmj.l393. No abstract available.

PMID:
30696635
7.

BRCA mutation screening and patterns among high-risk Lebanese subjects.

Farra C, Dagher C, Badra R, Hammoud MS, Alameddine R, Awwad J, Seoud M, Abbas J, Boulos F, El Saghir N, Mukherji D.

Hered Cancer Clin Pract. 2019 Jan 18;17:4. doi: 10.1186/s13053-019-0105-9. eCollection 2019.

8.

Phyllodes tumors of the breast treated in a tertiary health care center: case series and literature review.

Assi H, Salem R, Sukhon F, Abbas J, Boulos F, Saghir NE.

J Int Med Res. 2018 Oct 14:300060518803530. doi: 10.1177/0300060518803530. [Epub ahead of print]

PMID:
30318976
9.

American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions.

Hortobagyi GN, Pyle D, Cazap EL, El Saghir NS, Shulman LN, Lyman GH, Schnipper LE, Adebamowo CA, Gandara DR, Vose J, Wong SL, Yu P.

J Glob Oncol. 2018 Sep;4:1-8. doi: 10.1200/JGO.17.00060. Epub 2017 Aug 11.

10.

Cancer Care for Refugees and Displaced Populations: Middle East Conflicts and Global Natural Disasters.

El Saghir NS, Soto Pérez de Celis E, Fares JE, Sullivan R.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:433-440. doi: 10.1200/EDBK_201365. Review.

11.

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.

Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, Harbeck N, Aguilar Lopez B, Barrios CH, Bergh J, Biganzoli L, Boers-Doets CB, Cardoso MJ, Carey LA, Cortés J, Curigliano G, Diéras V, El Saghir NS, Eniu A, Fallowfield L, Francis PA, Gelmon K, Johnston SRD, Kaufman B, Koppikar S, Krop IE, Mayer M, Nakigudde G, Offersen BV, Ohno S, Pagani O, Paluch-Shimon S, Penault-Llorca F, Prat A, Rugo HS, Sledge GW, Spence D, Thomssen C, Vorobiof DA, Xu B, Norton L, Winer EP.

Ann Oncol. 2018 Aug 1;29(8):1634-1657. doi: 10.1093/annonc/mdy192. No abstract available.

12.

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.

Tripathy D, Im SA, Colleoni M, Franke F, Bardia A, Harbeck N, Hurvitz SA, Chow L, Sohn J, Lee KS, Campos-Gomez S, Villanueva Vazquez R, Jung KH, Babu KG, Wheatley-Price P, De Laurentiis M, Im YH, Kuemmel S, El-Saghir N, Liu MC, Carlson G, Hughes G, Diaz-Padilla I, Germa C, Hirawat S, Lu YS.

Lancet Oncol. 2018 Jul;19(7):904-915. doi: 10.1016/S1470-2045(18)30292-4. Epub 2018 May 24.

PMID:
29804902
13.

Prevalence and Severity of Sleep Disturbances among Patients with Early Breast Cancer.

Fakih R, Rahal M, Hilal L, Hamieh L, Dany M, Karam S, Shehab L, El Saghir NS, Tfayli A, Salem Z, Assi H, Temraz S, Shamseddine A, Mukherji D.

Indian J Palliat Care. 2018 Jan-Mar;24(1):35-38. doi: 10.4103/IJPC.IJPC_137_17.

14.

Dual HER2 Blockade.

Thomssen C, El Saghir NS, Francis PA, Jassem J, Rugo HS, Untch M.

Breast Care (Basel). 2017 Oct;12(5):345-349. doi: 10.1159/000484226. Epub 2017 Oct 30. No abstract available.

15.

microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis.

Nassar FJ, Talhouk R, Zgheib NK, Tfayli A, El Sabban M, El Saghir NS, Boulos F, Jabbour MN, Chalala C, Boustany RM, Kadara H, Zhang Z, Zheng Y, Joyce B, Hou L, Bazarbachi A, Calin G, Nasr R.

Sci Rep. 2017 Dec 4;7(1):16829. doi: 10.1038/s41598-017-16978-y.

16.

Reply to B.O. Anderson et al.

Chuang LT, El Saghir NS, Temin S, Berek JS.

J Glob Oncol. 2016 Aug 31;3(1):89-92. doi: 10.1200/JGO.2016.006262. eCollection 2017 Feb. No abstract available.

17.

Practice and Impact of Multidisciplinary Tumor Boards on Patient Management: A Prospective Study.

Charara RN, Kreidieh FY, Farhat RA, Al-Feghali KA, Khoury KE, Haydar A, Nassar L, Berjawi G, Shamseddine A, El Saghir NS.

J Glob Oncol. 2016 Aug 10;3(3):242-249. doi: 10.1200/JGO.2016.004960. eCollection 2017 Jun.

18.

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Penault-Llorca F, Piccart MJ, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E.

Ann Oncol. 2017 Dec 1;28(12):3111. doi: 10.1093/annonc/mdx036. No abstract available.

19.

Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective Analysis

Tfayli A, Rafei H, Mina A, Khalil M, Fakhreddin N, Mahfouz R, Hamouri S, Farhat F, Salem Z, Dbouk H, Rabee H, Saghir N, Shamseddine A, Makarem J, Bitar N, Mougharbil A, Assi H, Temraz S, Mukherji D, Matalka I, Zaatari G.

Asian Pac J Cancer Prev. 2017 Jan 1;18(1):107-114.

20.

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Penault-Llorca F, Piccart MJ, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E.

Ann Oncol. 2017 Jan 1;28(1):16-33. doi: 10.1093/annonc/mdw544. No abstract available. Erratum in: Ann Oncol. 2017 Dec 1;28(12 ):3111.

21.

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].

Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Penault-Llorca F, Piccart MJ, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E.

Breast. 2017 Apr;32:269-270. doi: 10.1016/j.breast.2017.01.001. Epub 2017 Jan 18. No abstract available.

PMID:
28109648
22.

Global Curriculum Edition 2016: European Society for Medical Oncology/American Society of Clinical Oncology Recommendations for Training in Medical Oncology.

Dittrich C, Kosty MP, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir NS, Lotz JP, Österlund P, Pavlidis N, Purkalne G.

J Clin Oncol. 2017 Jan 10;35(2):254-255. Epub 2016 Oct 31. Review. No abstract available.

PMID:
28056204
23.

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Penault-Llorca F, Piccart MJ, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E.

Breast. 2017 Feb;31:244-259. doi: 10.1016/j.breast.2016.10.001. Epub 2016 Dec 5. No abstract available. Erratum in: Breast. 2017 Apr;32:269-270.

24.

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV Jr, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y.

ESMO Open. 2016 Sep 29;1(5):e000097. eCollection 2016. Review.

25.

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe.

Pavlidis N, Alba E, Berardi R, Bergh J, El Saghir N, Jassem J, Kosty M, Lopez RI, Lotz JP, Österlund P, Purkalne G, Dittrich C.

ESMO Open. 2016 Jan 18;1(1):e000004. eCollection 2016. No abstract available.

26.

Research needs in breast cancer.

Cardoso F, Harbeck N, Barrios CH, Bergh J, Cortés J, El Saghir N, Francis PA, Hudis CA, Ohno S, Partridge AH, Sledge GW, Smith IE, Gelmon KA.

Ann Oncol. 2017 Feb 1;28(2):208-217. doi: 10.1093/annonc/mdw571.

27.

Improved Efficiency and Reliability of NGS Amplicon Sequencing Data Analysis for Genetic Diagnostic Procedures Using AGSA Software.

Poulet A, Privat M, Ponelle F, Viala S, Decousus S, Perin A, Lafarge L, Ollier M, El Saghir NS, Uhrhammer N, Bignon YJ, Bidet Y.

Biomed Res Int. 2016;2016:5623089. Epub 2016 Aug 30.

28.

ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016.

Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G; ESMO/ASCO Global Curriculum Working Group.

Ann Oncol. 2016 Aug;27(8):1378-81. doi: 10.1093/annonc/mdw239. No abstract available.

29.

A unilateral variation in the flexor digitorum superficialis with two distinct muscle bellies and associated tendons to the ring finger.

Saghir N, Saghir R, Shahid S, Hachach-Haram N, Johal K, Sojitra N.

J Plast Reconstr Aesthet Surg. 2016 Jun;69(6):869-870. doi: 10.1016/j.bjps.2016.03.018. Epub 2016 Mar 28. No abstract available.

PMID:
27053511
30.

Overview, prevention and management of chemotherapy extravasation.

Kreidieh FY, Moukadem HA, El Saghir NS.

World J Clin Oncol. 2016 Feb 10;7(1):87-97. doi: 10.5306/wjco.v7.i1.87. Review.

31.

The American Society of Clinical Oncology's Efforts to Support Global Cancer Medicine.

Hortobagyi GN, El-Saghir NS, Cufer T, Cazap E, de Guzman R, Othieno-Abinya NA, Sanchez JA, Pyle D.

J Clin Oncol. 2016 Jan 1;34(1):76-82. doi: 10.1200/JCO.2015.61.7696. Epub 2015 Nov 17. Review.

32.

Global Practice and Efficiency of Multidisciplinary Tumor Boards: Results of an American Society of Clinical Oncology International Survey.

El Saghir NS, Charara RN, Kreidieh FY, Eaton V, Litvin K, Farhat RA, Khoury KE, Breidy J, Tamim H, Eid TA.

J Glob Oncol. 2015 Oct 28;1(2):57-64. doi: 10.1200/JGO.2015.000158. eCollection 2015 Dec.

33.

A Cadaveric Study of the Branching Pattern and Diameter of the Genicular Arteries: A Focus on the Middle Genicular Artery.

Shahid S, Saghir N, Cawley O, Saujani S.

J Knee Surg. 2015 Oct;28(5):417-24. doi: 10.1055/s-0035-1549021. Epub 2015 Apr 18.

PMID:
25892007
34.

BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.

El Saghir NS, Zgheib NK, Assi HA, Khoury KE, Bidet Y, Jaber SM, Charara RN, Farhat RA, Kreidieh FY, Decousus S, Romero P, Nemer GM, Salem Z, Shamseddine A, Tfayli A, Abbas J, Jamali F, Seoud M, Armstrong DK, Bignon YJ, Uhrhammer N.

Oncologist. 2015 Apr;20(4):357-64. doi: 10.1634/theoncologist.2014-0364. Epub 2015 Mar 16.

35.

Breast cancer in low and middle income countries (LMICs): a shifting tide in global health.

Anderson BO, Ilbawi AM, El Saghir NS.

Breast J. 2015 Jan-Feb;21(1):111-8. doi: 10.1111/tbj.12357. Epub 2014 Nov 29.

PMID:
25444441
36.

Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer.

Haroun F, Al-Shaar L, Habib RH, El-Saghir N, Tfayli A, Bazarbachi A, Salem Z, Shamseddine A, Taher A, Cascorbi I, Zgheib NK.

Cancer Chemother Pharmacol. 2015 Jan;75(1):207-14. doi: 10.1007/s00280-014-2632-4. Epub 2014 Nov 27.

PMID:
25428516
37.

Enhancing cancer care in areas of limited resources: our next steps.

El Saghir NS, Farhat RA, Charara RN, Khoury KE.

Future Oncol. 2014 Oct;10(12):1953-65. doi: 10.2217/fon.14.124. Review.

38.

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E; European School of Oncology; European Society of Medical Oncology.

Breast. 2014 Oct;23(5):489-502. doi: 10.1016/j.breast.2014.08.009. Epub 2014 Sep 20. No abstract available.

39.

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E.

Ann Oncol. 2014 Oct;25(10):1871-88. doi: 10.1093/annonc/mdu385. Epub 2014 Sep 18. No abstract available.

40.

miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study.

Nassar FJ, El Sabban M, Zgheib NK, Tfayli A, Boulos F, Jabbour M, El Saghir NS, Talhouk R, Bazarbachi A, Calin GA, Nasr R.

PLoS One. 2014 Sep 18;9(9):e107566. doi: 10.1371/journal.pone.0107566. eCollection 2014.

41.

Outcome of Breast Cancer Patients Treated outside of Clinical Trials.

El Saghir NS, Assi HA, Jaber SM, Khoury KE, Nachef Z, Mikdashi HF, El-Asmar NS, Eid TA.

J Cancer. 2014 Jun 3;5(6):491-8. doi: 10.7150/jca.9216. eCollection 2014.

42.

Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide.

El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L.

Am Soc Clin Oncol Educ Book. 2014:e461-6. doi: 10.14694/EdBook_AM.2014.34.e461. Review.

43.

Management of Paclitaxel-induced hand-foot syndrome.

Assi HA, Ayoub ZA, Jaber SM, Sibai HA, El Saghir NS.

Breast Care (Basel). 2013 Jun;8(3):215-7. doi: 10.1159/000352097.

44.

Re: Tumor boards and the quality of cancer care.

El Saghir NS, Assi HA, Khoury KE, El Zawawy AM, Abbas JA, Eid TA.

J Natl Cancer Inst. 2013 Dec 4;105(23):1839. doi: 10.1093/jnci/djt312. Epub 2013 Nov 1. No abstract available.

PMID:
24187009
45.

Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.

Ganz PA, Yip CH, Gralow JR, Distelhorst SR, Albain KS, Andersen BL, Bevilacqua JL, de Azambuja E, El Saghir NS, Kaur R, McTiernan A, Partridge AH, Rowland JH, Singh-Carlson S, Vargo MM, Thompson B, Anderson BO.

Breast. 2013 Oct;22(5):606-15. doi: 10.1016/j.breast.2013.07.049. Epub 2013 Sep 3. Review.

PMID:
24007941
46.

Epidemiology and prognosis of breast cancer in young women.

Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS.

J Thorac Dis. 2013 Jun;5 Suppl 1:S2-8. doi: 10.3978/j.issn.2072-1439.2013.05.24.

47.

Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients: paving the way for OMICs in low and middle income countries.

Awada Z, Haider S, Tfayli A, Bazarbachi A, El-Saghir NS, Salem Z, Shamseddine A, Taher A, Zgheib NK.

OMICS. 2013 Jul;17(7):353-67. doi: 10.1089/omi.2013.0019. Epub 2013 Jun 11.

PMID:
23758476
48.

ASCO's International programs and how you can become involved.

El Saghir NS, Assi HA, Pyle D.

Am Soc Clin Oncol Educ Book. 2013:405-10. doi: 10.1200/EdBook_AM.2013.33.405. Review.

49.

Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.

Zgheib NK, Shamseddine AA, Geryess E, Tfayli A, Bazarbachi A, Salem Z, Shamseddine A, Taher A, El-Saghir NS.

Mutat Res. 2013 Jul-Aug;747-748:40-7. doi: 10.1016/j.mrfmmm.2013.04.004. Epub 2013 Apr 27.

PMID:
23628324
50.

Modern cancer management and research in the Middle East.

El Saghir NS.

Lancet Oncol. 2012 Nov;13(11):1076-8. doi: 10.1016/S1470-2045(12)70479-5. Epub 2012 Oct 19. No abstract available. Erratum in: Lancet Oncol. 2012 Dec;13(12):e520.

PMID:
23084765

Supplemental Content

Loading ...
Support Center